Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: Therapeutic implications for migraine and other pains

BACKGROUND: Meningeal and other trigeminal nociceptors are thought to play important roles in the initiation of migraine headache. Currently, the only approved peripherally administered chronic migraine prophylactic drug is onabotulinumtoxinA. The purpose of this study was to determine how botulinum...

Descripción completa

Detalles Bibliográficos
Autores principales: Burstein, Rami, Zhang, XiChun, Levy, Dan, Aoki, K Roger, Brin, Mitchell F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167963/
https://www.ncbi.nlm.nih.gov/pubmed/24694964
http://dx.doi.org/10.1177/0333102414527648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167963/
https://www.ncbi.nlm.nih.gov/pubmed/24694964
http://dx.doi.org/10.1177/0333102414527648

Ejemplares similares